Tamoxifen for women at high risk of breast cancer
Safia A Nazarali, Steven A Narod Women's College Research Institute, Women's College Hospital, and The University of Toronto, Toronto, Ontario, Canada Abstract: Tamoxifen has been used as a treatment for women who have been diagnosed with breast cancer for roughly four decades and...
Guardado en:
Autores principales: | Nazarali SA, Narod SA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f6dcb6d642a44e9ab0b890e2ff41d2a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
por: Katherine D. Crew, et al.
Publicado: (2017) -
MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
por: Sanne Løkkegaard, et al.
Publicado: (2021) -
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial
por: Andrea DeCensi, et al.
Publicado: (2021) -
Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients
por: Areepium N, et al.
Publicado: (2013) -
Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
por: Vogel VG
Publicado: (2011)